WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000025786) HETEROCYCLIC POTASSIUM CHANNEL INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/025786    International Application No.:    PCT/US1999/025066
Publication Date: 11.05.2000 International Filing Date: 26.10.1999
Chapter 2 Demand Filed:    19.05.2000    
IPC:
A61K 31/445 (2006.01), A61K 31/47 (2006.01), A61K 31/52 (2006.01), A61K 31/535 (2006.01), A61K 38/13 (2006.01), A61K 45/06 (2006.01), C07D 211/26 (2006.01), C07D 211/96 (2006.01)
Applicants: MERCK & CO., INC. [US/US]; 126 East Lincoln Avenue, Rahway, NJ 07065-0907 (US) (For All Designated States Except US).
BAO, Jianming [US/US]; (US) (For US Only).
KAYSER, Frank [DE/US]; (US) (For US Only).
KOTLIAR, Andrew [US/US]; (US) (For US Only).
PARSONS, William, H. [US/US]; (US) (For US Only).
RUPPRECHT, Kathleen, M. [US/US]; (US) (For US Only).
CLAIBORNE, Christopher, F. [US/US]; (US) (For US Only).
LIVERTON, Nigel [GB/US]; (US) (For US Only).
CLAREMON, David, A. [US/US]; (US) (For US Only).
THOMPSON, Wayne, J. [US/US]; (US) (For US Only)
Inventors: BAO, Jianming; (US).
KAYSER, Frank; (US).
KOTLIAR, Andrew; (US).
PARSONS, William, H.; (US).
RUPPRECHT, Kathleen, M.; (US).
CLAIBORNE, Christopher, F.; (US).
LIVERTON, Nigel; (US).
CLAREMON, David, A.; (US).
THOMPSON, Wayne, J.; (US)
Common
Representative:
MERCK & CO., INC.; 126 East Lincoln Avenue, Rahway, NJ 07065-0907 (US)
Priority Data:
60/106,292 30.10.1998 US
Title (EN) HETEROCYCLIC POTASSIUM CHANNEL INHIBITORS
(FR) INHIBITEURS HETEROCYCLIQUES DE CANAUX POTASSIQUES
Abstract: front page image
(EN)The present invention relates to a class of heterocyclic compounds of Formula (I) that are useful as potassium channel inhibitors to treat autoimmune disorders, cardiac arrhythmias, and the like.
(FR)La présente invention concerne une classe de composés hétérocycliques de formule (I), ces composés étant utilisés comme inhibiteurs de canaux potassiques afin de traiter les maladies auto-immunes, les arythmies cardiaques, et les troubles similaires.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)